US Patent 7304082 1,2,4-triazole derivatives, compositions, process of making and methods of use

Patent 7304082 was granted and assigned to Smithkline Beecham Limited on December, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Smithkline Beecham Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7304082

Date of Patent

December 4, 2007

Patent Application Number

11186519

Date Filed

July 21, 2005

Patent Primary Examiner

‌

Rebecca Anderson

Patent abstract

Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7304082 1,2,4-triazole derivatives, compositions, process of making and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API